30 November

The Forgotten Victims of Snakebite

12 October

Giving Snakebite Victims a Voice

4 May

Small country, big thinkers: Why it’s only natural for the Netherlands to take on a pioneering role in snakebite advocacy

15 February

European Commission Appoints Health Action International to HTA Network Stakeholder Pool

1 December

Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit

23 May

‘Achieiving Affordable Access to Health Technologies’ Side Event at WHA69

18 May

Top Experts to Discuss Global Initiatives to Reduce Snakebite Death & Disability at WHA69 Side Event

14 July

Can the WHO Set the Right Course for Antibiotics?

9 June

HAI urges MEPs to support key amendments to TTIP resolution

28 May

Successful week of advocacy for HAI delegation at 68th World Health Assembly

4 February

The EU-US Trade Deal Could Leave Europeans Sick

4 February

World Health Assembly Executive Board 136: YP-CDN, NWIA and HAI intervention on the WHO’s internship programme

2 February

World Health Assembly Executive Board 136: YP-CDN and HAI intervention on the progress achieved in the prevention and control of non-communicable diseases

15 October

EMA policy on clinical data publication a step ahead, but falls short of true potential

18 September

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry

16 September

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

5 June

Hoping for "harmony" on global antibiotic resistance strategy

28 May

Week in review: Outcomes from WHA67

28 May

Progress on access to medicines at WHA67, but WHO funding sorely needed

26 May

World Health Assembly: HAI and ARC intervention on antimicrobial resistance, including antibiotic resistance

26 May

World Health Assembly 67: HAI and KEI intervention on the Consultative Expert Working Group on Research and Development

26 May

World Health Assembly 67: HAI intervention on access to essential medicines

20 May

World Health Assembly 67: HAI intervention on the WHO's framework of engagement with non-state actors

10 April

Tamiflu review shows desperate need for full clinical trials data transparency

3 March

New materials help assess medicines policies and interventions

24 February

A new (and improved) model to regulate pharmaceutical promotion

12 February

Enhancing accountability in the medicines market: The Medicines Transparency Alliance

31 January

Leaks and Lies: Pharma’s strategy to derail South Africa’s intellectual property reforms exposed

30 January

Selected R&D demonstration projects disappointing: Innovation models with new incentive mechanisms needed

15 May

Bracing for another delay – open innovation at the WHO?